Abbvie Market capitalization 2024

Abbvie Market capitalization

319.76 B USD

Abbvie Dividend yield

3.28 %

Ticker

ABBV

ISIN

US00287Y1091

WKN

A1J84E

In 2024, Abbvie's market cap stood at 319.76 B USD, a 11.42% increase from the 286.98 B USD market cap in the previous year.

The Abbvie Market capitalization history

YEARREVENUE (undefined USD)GROSS MARGIN (%)NET INCOME (undefined USD)
2029e64.9555,5727.65
2028e64.3856,0626.95
2027e62.0358,1925.15
2026e63.2757,0524.25
2025e59.0561,1222
2024e55.6364,8820.16
202354.3266,454.82
202258.0571,5311.78
202156.269,1911.47
202045.866,694.56
201933.2777,147.84
201832.7576,935.66
201728.2274,635.28
201625.6477,325.92
201522.8680,315.14
201419.9677,831.77
201318.7975,624.13
201218.3875,475.28
201117.4473,643.43
201015.6472,594.18
200914.2171,464.64

Abbvie Aktienanalyse

What does Abbvie do?

Abbvie Inc. is a global, research-oriented company specializing in the field of biotechnology and pharmaceuticals. It was founded in 2013 as a spin-off from Abbott Laboratories. Abbvie's headquarters are in North Chicago, Illinois, and it employs over 47,000 people in more than 75 countries worldwide. The company focuses on researching, developing, and marketing high-quality therapies for the treatment of serious and life-threatening diseases. Abbvie has several business divisions, including immunology, oncology, neurology, and virology, and is known for its investments in research and development. Its key products include adalimumab (sold under the brand name Humira) for autoimmune diseases and Imbruvica for chronic lymphocytic leukemia. Abbvie is recognized as a leading company in the biotechnology and pharmaceutical industry due to its focus on innovative therapies and medicines. Abbvie ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Abbvie's Market Capitalization

Abbvie's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Abbvie's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Abbvie's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Abbvie’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Abbvie Stock

What is the current Abbvie market capitalization?

The current market capitalization of Abbvie is 319.76 B USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Abbvie.

How has the market capitalization of Abbvie developed in recent years?

The market capitalization of Abbvie has increased/decreased by 11.42% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Abbvie?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Abbvie?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Abbvie have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Abbvie pay?

Over the past 12 months, Abbvie paid a dividend of 5.92 USD . This corresponds to a dividend yield of about 3.28 %. For the coming 12 months, Abbvie is expected to pay a dividend of 6.04 USD.

What is the dividend yield of Abbvie?

The current dividend yield of Abbvie is 3.28 %.

When does Abbvie pay dividends?

Abbvie pays a quarterly dividend. This is distributed in the months of August, November, February, May.

How secure is the dividend of Abbvie?

Abbvie paid dividends every year for the past 101 years.

What is the dividend of Abbvie?

For the upcoming 12 months, dividends amounting to 6.04 USD are expected. This corresponds to a dividend yield of 3.35 %.

In which sector is Abbvie located?

Abbvie is assigned to the 'Health' sector.

Wann musste ich die Aktien von Abbvie kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Abbvie from 5/15/2024 amounting to 1.55 USD, you needed to have the stock in your portfolio before the ex-date on 4/12/2024.

When did Abbvie pay the last dividend?

The last dividend was paid out on 5/15/2024.

What was the dividend of Abbvie in the year 2023?

In the year 2023, Abbvie distributed 5.64 USD as dividends.

In which currency does Abbvie pay out the dividend?

The dividends of Abbvie are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Abbvie stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Abbvie

Our stock analysis for Abbvie Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abbvie Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.